Meet a Study Watch for Clinical Research

The Study Watch is an investigational device and is not available for sale.

Meet a Study Watch for Clinical Research

Google has introduced a study watch that has the ability to passively capture health data, which is critical to the success of continuous care platforms and clinical research.

According to the search giant, the watch was developed by Verily, an Alphabet (Google’s parent company) subsidiary that was founded in 2015 to focus on life sciences and healthcare.

“Study Watch represents another step in our targeted efforts to create new tools for unobtrusive biosensing,” the company said in a blog post.

“While numerous wearables exist in the market, we have a specific need outside of these offerings: namely, the scalable collection of rich and complex datasets across clinical and observational studies”

The Study Watch is an investigational device and is not available for sale.

Verily said the watch was designed with input from users, researchers, and clinicians, and features multiple physiological and environmental sensors are designed to measure relevant signals for studies spanning cardiovascular, movement disorders, and other areas.

Large internal storage and data compression allow the device to store weeks’ worth of raw data, thus relaxing the need to frequently sync the device. The watch has a powerful processor that supports real-time algorithms on the device.

To ensure the privacy of data, Verily said because the investigational device stores health data, all data are encrypted on the device for security

“The encrypted data are uploaded and processed in the cloud using Verily’s backend algorithms and machine learning tools. This infrastructure is highly scalable and can serve population studies consisting of large volumes of data,” the company said in a blog.

According to the Alphabet company, the Study Watch will be used in several observational studies conducted by Verily’s partners, including the Personalized Parkinson’s Project, a multi-year study to identify patterns in the progression of Parkinson’s disease and provide a foundation for more personalised treatments. Also, Study Watch will be used in the forthcoming Baseline study, a longitudinal study exploring transitions between health and disease. In the future.

“We plan to incorporate Study Watch in a broad array of health applications,” said the company.

COMMENTS

WORDPRESS: 0
DISQUS: 0
%d bloggers like this: